[Significance of peripheral catecholamine mechanisms in effecting a reserpine-induced central activation of the pituitary-adrenal system].
D000311:Adrenal Glands / Q000378:metabolism / Q000502:physiology; D000313:Adrenal Medulla / Q000502:physiology; D000315:Adrenalectomy; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D001205:Ascorbic Acid / Q000378:metabolism; D001949:Bretylium Compounds / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D004876:Ergot Alkaloids / Q000494:pharmacology; D005260:Female; D005730:Ganglionic Blockers / Q000494:pharmacology; D005938:Glucocorticoids / Q000097:blood; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008297:Male; D010393:Pempidine / Q000494:pharmacology; D005082:Physical Exertion; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*; D011984:Sensory Receptor Cells / Q000187:drug effects*; D013564:Sympathetic Nervous System / Q000187:drug effects*
D000317:Adrenergic alpha-Antagonists; D001949:Bretylium Compounds; D004876:Ergot Alkaloids; D005730:Ganglionic Blockers; D005938:Glucocorticoids; D006584:Hexamethonium Compounds; D003983:Dibenzylchlorethamine; D012110:Reserpine; D000324:Adrenocorticotropic Hormone; D010393:Pempidine; D001205:Ascorbic Acid; D002746:Chlorpromazine
Znachenie perifericheskikh katekholaminovykh mekhanizmov v osushchestvlenii vyzyvaemoĭ rezerpinom tsentral'noĭ aktivatsii gipofizarno-adrenokortikal'noĭ sistemy.